Antagonism of leukocyte adherence by synthetic fibronectin peptide V in a rat model of transient focal cerebral ischemia

Neurosurgery

Volumn 40, Issue 3, 1997, Pages 557-564

  Yanaka, Kiyoyuki ^a,b   Camarata, Paul J ^a,b   Spellman, Stephen R ^a,b   McCarthy, James B ^a,b   Furcht, Leo T ^a,b   Low, Walter C ^a,b  

^a Departments of Neurosurgery   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Adhesion molecules; Cerebral ischemia; Fibronectin; Leukocytes; Peptides; Rats

Indexed keywords

FIBRONECTIN; MYELOPEROXIDASE; SYNTHETIC PEPTIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; ENZYME ACTIVITY; EXPERIMENTAL MODEL; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE ADHERENCE; NEUROLOGICAL COMPLICATION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; BRAIN DAMAGE, CHRONIC; CEREBRAL INFARCTION; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRONECTINS; ISCHEMIC ATTACK, TRANSIENT; LEUKOCYTE ADHERENCE INHIBITION TEST; LEUKOCYTE COUNT; LEUKOCYTES; MALE; NEUROLOGIC EXAMINATION; PEPTIDE FRAGMENTS; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 0031034908     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199703000-00026     Document Type: Article

References (33)

1. Akiyama SK, Yamada KM: Fibronectin. Adv Enzymol Relat Areas Mol Biol 59:1-57, 1987.
2. Barone FC, Hillegass LM, Price WJ, White RF, Lee EV, Feuerstein GZ, Sarau HM, Clark RK, Griswold DE: Polymorphonuclear leukocyte infiltration into cerebral focal ischémie tissue: Myeloperoxidase activity assay and histology verification. J Neurosci Res 29:336-345, 1994.
3. Bevilacqua MP, Nelson RM: Selectins. J Clin Invest 91:379-387, 1993.
4. Bowes MP, Rothlein R, Pagan SC, Zivin D: Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy. Neurology 45:815-819, 1995.
5. Bowes MP, Zivin JA, Rothlein R: Monoclonal antibody to the ICAM-1 adhesion site reduces neurological damage in a rabbit cerebral embolism stroke model. Exp Neurol 119:215-219, 1993.
6. Bradley PP, Priebat DA, Christensen RD, Rothstein G: Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78:206-209,1982.
7. Butcher EC: Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity. Cell 67:1033-1036, 1991.
8. Clark RK, Lee EV, Fish CJ, White RF, Price VVJ, Jonak ZL, Feuerstein GZ, Barone FC: Development of tissue damage, inflammation and resolution following stroke: An immunohistochemical and quantitative planimetric study. Brain Res Bull 31: 565-572, 1993.
9. Diamond S, Alon R, Parkos CA, Quinn MT, Springer TA: Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CDllb/CD18). J Cell Biol 130:1473-1482, 1995.
10. Guan JL, Hynes RO: Lymphoid cells recognize an alternatively spliced segment of fibronectin via the integrin receptor alpha 4/beta 1. Cell 60:53-61, 1990.
11. Hakkert BC, Kuijpers TVV, Leeuwenberg JFM, van Mourik JA, Roos D: Neutrophil and monocyte adherence to and migration across monolayers of cytokine-activated endothelial cells: The contribution of CD18, ELAM-1, and VLA-4. Blood 78:2721-2726, 1991.
12. Hallenbeck JM, Dutka AJ, Tanishima T, Kochanek PM, Kumaroo KK, Thompson CB, Obrenovitch TP, Contreras TJ: Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early post ischémie period. Stroke 17:246-253, 1986.
13. Harkness JE, Wagner JE: The Biology and Medicine of Rabbits and Rodents. Philadelphia, Lea & Febiger, ed 3, 1986.
14. Hemler ME: VLA proteins in the integrin family: Structures, functions, and their role in leukocytes. Ann Rev Immunol 8:365-400, 1990.
15. Hines KL, Kulkarni AB, McCarthy JB, Tian H, Ward JM, Christ M, McCartney-Francis NL, Furcht LT, Karlsson S, Wahl SM: Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor ß1 knockout mice. Proc Natl Acad Sci U S A 91:5187-5191, 1994.
16. Hynes RO: Integrins: A family of cell surface receptors. Cell 48:549-554, 1987.
17. lida J, Skubits APN, Furcht LT, Wayner EA, McCarthy JB: Coordinate role for cell surface chondroitin sulfate proteoglycan and a4ßl integrin in mediating melanoma cell adhesion to fibronectin. J Cell Biol 118:431-444, 1992.
18. Kochanek PM, Hallenbeck JM: Polymorphonuclear leukocytes and monocy tes /macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 23:1367-1379, 1992.
19. Lasky LA: Selectins: Interpreters of cell-specific carbohydrate information during inflammation. Science 258:964-969, 1992.
20. Matsuo Y, Kihara T, Ikeda M, Ninomiya M, Onodera H, Kogure K: Roll of neutrophils in radical production during ischemia and repcrfusion of the rat brain: Effect of neutrophil depletion on extracellular ascorbyl radical formation. J Cereb Blood Flow Mctab 15:941-947, 1995.
21. Matsuo Y, Onodera H, Shiga Y, Nakamura M, Ninomiya M, Kihara T, Kogure K: Correlation between myeloperoxidasequantified neutrophil accumulation and ischémie brain injury in the rat: Effects of neutrophil depletion. Stroke 25:1469-1475,1994.
22. McCarthy JB, Chelberg MK, Mickelson DJ, Furcht LT: Localization and chemical synthesis of fibronectin peptides \vith melanoma adhesion and heparin binding activities. Biochemistry 27: 1380-1388, 1988.
23. Norgard-Sumnichit KE, Varki NM, Varki A: Calcium-dependent heparin-like ligands for L-selectin in nonlymphoid endothelial cells. Science 261:480-483, 1993.
24. Osborne L: Leukocyte adhesion to endothelium in inflammation. Cell 62:3-6, 1990.
25. Ruoslahti E: Integrins. J Clin Invest 87:1-5, 1991.
26. Springer TA: Adhesion receptors of the immune system. Nature 346:425-434, 1990.
27. Wahl SM, Allen JB, Hines KL, Wahl AM, Furcht LT, McCarthy JB: Synthetic fibronectin peptides suppress arthritis in rats by interrupting leukocyte adhesion and recruitment. J Clin Invest 94: 655-662, 1994.
28. Woods A, McCarthy JB, Furcht LT, Couchman JR: A synthetic peptide from the COOH-terminal heparin-binding domain of fibronectin promotes focal adhesion formation. Mol Biol Cell 4:605-613, 1993.
29. Yanaka K, Camarata PJ, Spellman SR, McCarthy JB, Furcht LT, Low WC, Heros RC: Synthetic fibronectin peptides and ischémie brain injury after transient middle cerebral artery occlusion in rats. J Neurosurg 85:125-130, 1996.
30. Yanaka K, Camarata PJ, Spellman SR, McCarthy JB, Furcht LT, Low WC, Heros RC: Neuronal protection from cerebral ischemia by synthetic fibronectin peptides to leukocyte adhesion molecules. J Cereb Blood Flow Metab 16:1120-1125, 1996.
31. Yanaka K, Camarata PJ, Spellman SR, McDonald DE, Heros RC: Optimal timing of hemodilution for brain protection in a canine model of focal cerebral ischemia. Stroke 27:906-912, 1996.
32. Zea Longa E, Weinstein PR, Carlson S, Cummins R: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84-91, 1989.
33. Zhang RL, Chopp M, Jiang N, Tang WX, Prostak J, Manning AM, Anderson DC: Anti-intercellular adhesion molecule-1 antibody reduces ischémie cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat. Stroke 26:1438-1443, 1995.